全文获取类型
收费全文 | 90228篇 |
免费 | 8510篇 |
国内免费 | 4565篇 |
专业分类
耳鼻咽喉 | 1042篇 |
儿科学 | 980篇 |
妇产科学 | 1387篇 |
基础医学 | 11813篇 |
口腔科学 | 2021篇 |
临床医学 | 9151篇 |
内科学 | 14905篇 |
皮肤病学 | 1455篇 |
神经病学 | 5434篇 |
特种医学 | 3337篇 |
外国民族医学 | 17篇 |
外科学 | 12014篇 |
综合类 | 11998篇 |
现状与发展 | 15篇 |
一般理论 | 7篇 |
预防医学 | 5937篇 |
眼科学 | 2239篇 |
药学 | 8973篇 |
34篇 | |
中国医学 | 3434篇 |
肿瘤学 | 7110篇 |
出版年
2024年 | 216篇 |
2023年 | 1046篇 |
2022年 | 2321篇 |
2021年 | 2973篇 |
2020年 | 2270篇 |
2019年 | 2052篇 |
2018年 | 2576篇 |
2017年 | 2300篇 |
2016年 | 2133篇 |
2015年 | 2913篇 |
2014年 | 3585篇 |
2013年 | 3981篇 |
2012年 | 5346篇 |
2011年 | 5547篇 |
2010年 | 3760篇 |
2009年 | 3268篇 |
2008年 | 4072篇 |
2007年 | 4135篇 |
2006年 | 3726篇 |
2005年 | 3263篇 |
2004年 | 2512篇 |
2003年 | 2283篇 |
2002年 | 2077篇 |
2001年 | 5233篇 |
2000年 | 5081篇 |
1999年 | 4405篇 |
1998年 | 1619篇 |
1997年 | 1254篇 |
1996年 | 821篇 |
1995年 | 686篇 |
1994年 | 605篇 |
1993年 | 488篇 |
1992年 | 2012篇 |
1991年 | 1752篇 |
1990年 | 1603篇 |
1989年 | 1545篇 |
1988年 | 1348篇 |
1987年 | 1222篇 |
1986年 | 1087篇 |
1985年 | 910篇 |
1984年 | 603篇 |
1983年 | 468篇 |
1982年 | 258篇 |
1981年 | 189篇 |
1980年 | 141篇 |
1979年 | 284篇 |
1978年 | 88篇 |
1974年 | 79篇 |
1973年 | 99篇 |
1972年 | 78篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
In this paper the immunosuppressive effects of Gui Zhi Tang (a famous Chinese medicine) on the murine immune functions are reported. Varying dosages of Gui Zhi Tang administrated orally, i.p. and i.m. were able to inhibit the amounts of PFC, SRFC and the DTH response induced by BSA and the proliferation response of murine spleen cells to Con A and LPS. Further studies showed that Gui Zhi Tang had the inhibitory effect on Interleukin-2 production of murine spleen cells, which might be one of the mechanisms leading to the immunosuppressive effects of Gui Zhi Tang. 相似文献
103.
104.
105.
目的检测以质粒pIRES为载体构建的带有全序列癌胚抗原(CEA)基因的核苷酸疫苗对机体特异性抗肿瘤免疫反应的激活效果。方法将CEA基因片段连接于真核表达质粒pIRES中,用肌肉注射方法接种核酸疫苗;检测CEA在小鼠肌肉组织中的表达情况及其对小鼠脾细胞CEA特异性细胞免疫反应的激活效果。结果小鼠经肌肉注射质粒后,免疫组化证实该核酸疫苗可在体内有效表达CEA;分子免疫检测显示注射后小鼠特异性淋巴细胞增值反应明显并且伴有自然杀伤细胞NK活性显著增高。结论实验所构建的核酸疫苗pIRESCEA可在体外及小鼠体内高效表达并表现出良好的细胞免疫原性。 相似文献
106.
107.
108.
N Curcó† X Pagerols† M García† X Tarroch‡ P Vives† 《Journal of the European Academy of Dermatology and Venereology》2006,20(3):331-333
A 40-year-old man presented a painful haemorrhagic plaque on his chest in the same location where a nodular lesion had been presented for many years. After 2 months, the plaque was replaced by a depressed lesion. The lesion diagnosed as an anetoderma was excised and the biopsy showed an atrophic dermatofibroma accompanied by aneurysmatic characteristics. 相似文献
109.
X Z Huang 《中华结核和呼吸杂志》1991,14(4):225-7, 256
Sixteen patients (male: 14, female: 2, 41-72 yrs, mean 57.5 yrs) with OSAS were treated by nCPAP in our hospital since 1987. Respiratory disturbance index ranged from 16.5 to 83.1. The longest apnea duration was 35.0-120.5 seconds before the treatment. Two patients were treated with Sleep Easy III (Respironics Inc.) and others with a home made instruments. nCPAP was set at a pressure of 5 to 10 cm H2O. 12 patients (75%) tolerated the device but 4(25%) did not. Polysomnographic parameters before and after nCPAP therapy were compared. The longest apnea duration was 63.1 +/- 23.5 to 40.9 +/- 27.4 seconds (P less than 0.001) and the lowest saturation oxygen was 55.1 +/- 20.4% to 71.4 +/- 18.6% (P less than 0.05). The sleep structure improved but not significant statistically. One of them used nCPAP at home for more than two. years and showed a good long term effect. We concluded that nCPAP is an effective and safe treatment for OSAS. However, patients may be uncomfortable because of the wearing of the nasal mask during sleep. 相似文献
110.
Steven N Singh X Charlene Tang Bramah N Singh Paul Dorian Domenic J Reda Crystal L Harris Ross D Fletcher Satish C Sharma J Edwin Atwood Alan K Jacobson H Daniel Lewis Becky Lopez Dennis W Raisch Michael D Ezekowitz 《Journal of the American College of Cardiology》2006,48(4):721-730
OBJECTIVES: The purpose of this study was to determine quality of life (QOL) and exercise performance (EP) in patients with persistent atrial fibrillation (AF) converted to sinus rhythm (SR) compared with those remaining in or reverting to AF. BACKGROUND: Restoration of SR in patients with AF improving QOL and EP remains controversial. METHODS: Patients with persistent AF were randomized double-blind to amiodarone, sotalol, or placebo. Those not achieving SR at day 28 were cardioverted and classified into SR or AF groups at 8 weeks (n = 624) and 1 year (n = 556). The QOL (SF-36), symptom checklist (SCL), specific activity scale (SAS), AF severity scale (AFSS), and EP were assessed. RESULTS: Favorable changes were seen in SR patients at 8 weeks in physical functioning (p < 0.001), physical role limitations (p = 0.03), general health (p = 0.002), and vitality (p < 0.001), and at 1 year in general health (p = 0.007) and social functioning (p = 0.02). Changes in the scores for SCL severity (p = 0.01), functional capacity (p = 0.003), and AFSS symptom burden (p < 0.001) at 8 weeks and in SCL severity (p < 0.01) and AF symptom burden (p < 0.001) at 1 year showed significant improvements in SR versus AF. Symptomatic patients were more likely to have improvement. The EP in SR versus AF was greater from baseline to 8 weeks (p = 0.01) and to 1 year (p = 0.02). The EP correlated with physical functioning and functional capacity except in the AF group at 1 year. CONCLUSIONS: In patients with persistent AF, restoration and maintenance of SR was associated with improvements in QOL measures and EP. There was a strong correlation between QOL measures and EP. 相似文献